A multicenter, randomized, double blind, placebo controlled multiple dose study of the efficacy and safety of AS-3201 in patients with DSP (diabetic sensorimotor polyneuropathy). [Phase II]

Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2007
This article has no abstract
Epistemonikos ID: 2f8d1e603383818a3f3e95b8405ca3dc0ebc6972
First added on: Apr 16, 2025